Pangaea Data

Pangaea Data Limited have pioneered a product based on their novel unsupervised AI to unlock hidden value from unstructured textual health data, which comprises 80% of patient records and 90% of medical blogs and social media feeds. Pangaea's product is used by scientists from the biopharmaceutical industry to extract intelligence such as phenotype... s (clinical features) so they can stratify patients effectively and find more patients for drug discovery, clinical trial and new product launches at scale, which is otherwise challenging, especially in the context of hard to diagnose conditions such as rare and chronic diseases where 60% of the patient population is not diagnosed accurately. The company has access to more than 500 million patient electronic health records in a privacy preserving federated manner through its partnerships with hospitals and other such providers from the US, UK, Europe, South America and Asia Pacific. Biopharmaceutical companies are also using the product to automatically generate clinical study reports and the likes from experimental data and to find adverse events for pharmacovigilance. Pangaea continually publish their work in high impact peer reviewed journals. Pangaea is based in San Francisco, London and Hong Kong and was founded by experienced entrepreneurs who have raised more than £130 million through their academic research and is advised by leading experts from industry, Imperial College London and Stanford University.Read More